These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease. Damalanka VC; Kim Y; Galasiti Kankanamalage AC; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC Eur J Med Chem; 2017 Feb; 127():41-61. PubMed ID: 28038326 [TBL] [Abstract][Full Text] [Related]
4. Structural and inhibitor studies of norovirus 3C-like proteases. Takahashi D; Kim Y; Lovell S; Prakash O; Groutas WC; Chang KO Virus Res; 2013 Dec; 178(2):437-44. PubMed ID: 24055466 [TBL] [Abstract][Full Text] [Related]
5. Structure-based design and synthesis of triazole-based macrocyclic inhibitors of norovirus protease: Structural, biochemical, spectroscopic, and antiviral studies. Weerawarna PM; Kim Y; Galasiti Kankanamalage AC; Damalanka VC; Lushington GH; Alliston KR; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC Eur J Med Chem; 2016 Aug; 119():300-18. PubMed ID: 27235842 [TBL] [Abstract][Full Text] [Related]
6. Structure-based exploration and exploitation of the S Galasiti Kankanamalage AC; Kim Y; Rathnayake AD; Damalanka VC; Weerawarna PM; Doyle ST; Alsoudi AF; Dissanayake DMP; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC Eur J Med Chem; 2017 Jan; 126():502-516. PubMed ID: 27914364 [TBL] [Abstract][Full Text] [Related]
7. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796 [TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Discovery of Norovirus Therapeutics. Kim Y; Galasiti Kankanamalage AC; Chang KO; Groutas WC J Med Chem; 2015 Dec; 58(24):9438-50. PubMed ID: 26258852 [TBL] [Abstract][Full Text] [Related]
9. A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor. Hussey RJ; Coates L; Gill RS; Erskine PT; Coker SF; Mitchell E; Cooper JB; Wood S; Broadbridge R; Clarke IN; Lambden PR; Shoolingin-Jordan PM Biochemistry; 2011 Jan; 50(2):240-9. PubMed ID: 21128685 [TBL] [Abstract][Full Text] [Related]
10. Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors. Chang KO; Kim Y; Lovell S; Rathnayake AD; Groutas WC Viruses; 2019 Feb; 11(2):. PubMed ID: 30823509 [TBL] [Abstract][Full Text] [Related]
11. Structure(s), function(s), and inhibition of the RNA-dependent RNA polymerase of noroviruses. Deval J; Jin Z; Chuang YC; Kao CC Virus Res; 2017 Apr; 234():21-33. PubMed ID: 28041960 [TBL] [Abstract][Full Text] [Related]
12. Current tools for norovirus drug discovery. Weerasekara S; Prior AM; Hua DH Expert Opin Drug Discov; 2016 Jun; 11(6):529-41. PubMed ID: 27108716 [TBL] [Abstract][Full Text] [Related]
13. Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus. Mandadapu SR; Weerawarna PM; Prior AM; Uy RA; Aravapalli S; Alliston KR; Lushington GH; Kim Y; Hua DH; Chang KO; Groutas WC Bioorg Med Chem Lett; 2013 Jul; 23(13):3709-12. PubMed ID: 23727045 [TBL] [Abstract][Full Text] [Related]
14. Norovirus Protease Structure and Antivirals Development. Zhao B; Hu L; Song Y; Patil K; Ramani S; Atmar RL; Estes MK; Prasad BVV Viruses; 2021 Oct; 13(10):. PubMed ID: 34696498 [TBL] [Abstract][Full Text] [Related]
15. Norovirus gastroenteritis, increased understanding and future antiviral options. Tan M; Jiang X Curr Opin Investig Drugs; 2008 Feb; 9(2):146-51. PubMed ID: 18246517 [TBL] [Abstract][Full Text] [Related]